Riverbridge Partners’s Halozyme HALO Stock Holding History

Riverbridge Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$14.6M	Buy	+132,015	New	+$12.7M	0.43%	60

Other funds holding HALO

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.9B AUM 30.31% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Riverbridge Partners's HALO Position: Q3 2026 in Review

Riverbridge Partners opened a new position in Halozyme (HALO) in Q3 2026: 132,015 shares worth $14.6M. The stake represents 0.43% of the portfolio and ranks #60 among its holdings.

346 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

Riverbridge Partners held 132,015 shares of Halozyme worth $14.6M as of Q3 2026.
Halozyme was a new Riverbridge Partners position in Q3 2026.
Halozyme made up 0.43% of Riverbridge Partners's portfolio in Q3 2026, its #60 holding.
346 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Riverbridge Partners's 13F filing for Q3 2026, filed 5 Nov 2026.